Market Insights

CVS Health Tops Q1 Street View On Earnings

CVS Health Tops Q1 Street View On Earnings

May 4, 2018 at 1:31 pm

CVS Health (CVS) shares were over 1% higher pre-market Wednesday after the pharmacy chain topped Q1 Street views on earnings, despite a slight miss on revenue. The company also issued guidance above Street views. The company reported Q1 adjusted EPS of $1.48, up from $1.17 a year earlier, and also above the $1.40 Street view,as compiled by Capital IQ. CVSRead More

Tyler Technologies Slips Though Q1 Beats Estimates

Tyler Technologies Slips Though Q1 Beats Estimates

May 4, 2018 at 1:30 pm

Tyler Technologies (TYL) fell 2% after the company said Q1 sales rose 10.7% to $221.2 million from the year-ago period and topped the CapIQ mean for $219.4 million. Non-GAAP EPS rose 27.5% to $1.13 from last year and beat by a penny. Net income per share rose 15.4% to $0.95, a dime above forecasts. 2018 sales are seen between $933Read More

Stoneridge Q1 Revenue Up

Stoneridge Q1 Revenue Up

May 4, 2018 at 1:29 pm

Stoneridge (SRI) on Wednesday reported Q1 revenue of $225.9 million, compared with $204.3 million in the year-ago quarter. Analysts polled by Capital IQ were expecting revenue of $213.94 million. Net income for the quarter ended March 31 was $0.50 per share, compared with $0.32 per share in the year-ago period. Analysts were expecting EPS of $0.48. The company expects full-yearRead More

DexCom Q1 Beats Estimates

DexCom Q1 Beats Estimates

May 4, 2018 at 1:27 pm

DexCom’ (DXCM) adjusted net loss narrowed to $0.32 per share in Q1 from $0.49 loss per share a year earlier, a smaller loss than analysts’ estimates of $0.36 loss per share in a Capital IQ poll. Revenue grew 30% versus the same quarter of the prior year to $184.4 million, exceeding the $172.66 million estimate. For 2018. the company nowRead More

Olin Q1 Mixed Estimates

Olin Q1 Mixed Estimates

May 4, 2018 at 1:26 pm

Olin’s (OLN) diluted EPS rose to $0.12 in Q1 from $0.08 a year earlier, but still missing analysts’ estimates of $0.19 in a Capital IQ poll. Revenue rose to $1.71 billion from $1.57 billion, exceeding the $1.62 billion estimate. Based on the positive outlook for both Chlor Alkali Products and Vinyls and Epoxy pricing and volumes, the company said itsRead More

Anika Therapeutics Due Off Halt at 435 PM ET

Anika Therapeutics Due Off Halt at 435 PM ET

May 2, 2018 at 4:28 pm

Anika Therapeutics (ANIK) is due off a trading halt at 435 PM ET. The company said Q1 sales slipped to $21.3 million from the year-ago period’s $23.4 million and missesd the CapIQ mean for $24.3 milllion. It swung to a net loss per share of $0.46 from a $0.37 profit last year and missed forecasts for a quarter gain. ItRead More

Square Q1 Results Top Expectations; Shares Fall After Hours

Square Q1 Results Top Expectations; Shares Fall After Hours

May 2, 2018 at 4:26 pm

Square (SQ) reported adjusted net income of $0.06 per share in Q1, a penny better than the consensus on Capital IQ and compared with the year earlier gain of $0.05 a share. The payments company’s stock was down about 5% in early after-hours trading. Adjusted revenue surged 51% to $307 million, ahead of the analysts’ views for $293.1 million. SquareRead More